Trial Profile
Tolerability of crisantaspase [L-asparaginase Erwinia chrysanthemi; Erwinaze] in patients with acute lymphoblastic leukaemia who developed hypersensitivity to Escherichia coli-derived asparaginase: compassionate use protocol
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2012
Price :
$35
*
At a glance
- Drugs Crisantaspase (Primary) ; Antineoplastics
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- Sponsors Jazz Pharmaceuticals plc
- 20 Dec 2012 New trial record
- 10 Dec 2012 Data were presented at the American Society of Hematology Annual Meeting and Exposition, according to a Jazz Pharmaceuticals plc media release.